Browse our anti-MAP3K7 (MAP3K7) Antibodies

Full name:
anti-Mitogen-Activated Protein Kinase Kinase Kinase 7 Antibodies (MAP3K7)
On www.antibodies-online.com are 175 Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7) Antibodies from 17 different suppliers available. Additionally we are shipping MAP3K7 Kits (10) and MAP3K7 Proteins (6) and many more products for this protein. A total of 211 MAP3K7 products are currently listed.
Synonyms:
B430101B05, C87327, MEKK7, si:ch211-225h9.1, TAK1, TGF1a, zgc:110612
list all antibodies Gene Name GeneID UniProt
MAP3K7 313121 P0C8E4
MAP3K7 6885 O43318
MAP3K7 26409 Q62073

Show all species

Show all synonyms

Most Popular Reactivities for anti-MAP3K7 (MAP3K7) Antibodies

Select your species and application

anti-Rat (Rattus) MAP3K7 Antibodies:

anti-Human MAP3K7 Antibodies:

anti-Mouse (Murine) MAP3K7 Antibodies:

All available anti-MAP3K7 Antibodies

Go to our pre-filtered search.

Top referenced anti-MAP3K7 Antibodies

  1. Human Polyclonal MAP3K7 Primary Antibody for EIA - ABIN358291 : Ono, Ohtomo, Ninomiya-Tsuji, Tsuchiya: A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-beta. in Biochemical and biophysical research communications 2003 (PubMed)
    Show all 5 references for 358291

  2. Human Polyclonal MAP3K7 Primary Antibody for DB, EIA - ABIN358312 : Smit, Baas, Kuipers, Korswagen, van de Wetering, Clevers: Wnt activates the Tak1/Nemo-like kinase pathway. in The Journal of biological chemistry 2004 (PubMed)
    Show all 5 references for 358312

  3. Human Polyclonal MAP3K7 Primary Antibody for EIA, IHC (p) - ABIN360354 : Takaesu, Surabhi, Park, Ninomiya-Tsuji, Matsumoto, Gaynor: TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. in Journal of molecular biology 2003 (PubMed)
    Show all 5 references for 360354

  4. Human Polyclonal MAP3K7 Primary Antibody for ELISA, WB - ABIN185640 : Omori, Matsumoto, Sanjo, Sato, Akira, Smart, Ninomiya-Tsuji: TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. in The Journal of biological chemistry 2006 (PubMed)
    Show all 2 references for 185640

  5. Human Polyclonal MAP3K7 Primary Antibody for IHC, ELISA - ABIN1532056 : Mungall, Palmer, Sims, Edwards, Ashurst, Wilming, Jones, Horton, Hunt, Scott, Gilbert, Clamp, Bethel, Milne, Ainscough, Almeida, Ambrose, Andrews, Ashwell, Babbage, Bagguley, Bailey, Banerjee, Barker et al.: The DNA sequence and analysis of human chromosome 6. ... in Nature 2003 (PubMed)
    Show all 2 references for 1532056

  6. Human Polyclonal MAP3K7 Primary Antibody for ELISA, WB - ABIN1532055 : Shibuya, Yamaguchi, Shirakabe, Tonegawa, Gotoh, Ueno, Irie, Nishida, Matsumoto: TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. in Science (New York, N.Y.) 1996 (PubMed)
    Show all 2 references for 1532055

More Antibodies against MAP3K7 Interaction Partners

Human Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7) interaction partners

  1. TAK1 regulates Nrf2 (show GABPA Antibodies) through modulation of Keap-p62/SQSTM1 (show SQSTM1 Antibodies) interaction. This regulation is important for homeostatic antioxidant protection in the intestinal epithelium.

  2. Overexpression of TAK1 was strongly associated with positive lymph node metastasis in pancreatic ductal adenocarcinoma.

  3. dysregulation of the TAK1 complex produces a close phenocopy of Frontometaphyseal Dysplasia caused by FLNA (show FLNA Antibodies) mutations; furthermore, the pathogenesis of some of the filaminopathies caused by FLNA (show FLNA Antibodies) mutations might be mediated by misregulation of signaling coordinated through the TAK1 signaling complex

  4. although TAK1 is located at the crossroad of inflammation, immunity, and cancer, this study reports MAP3K7 mutations in a developmental disorder affecting mainly cartilage, bone, and heart

  5. This study suggests that aberrant activity of TAK1 impairs autophagy and subsequently leads to alterations in the vitality of retinal pigment epithelial cells.

  6. TAK1 may be an important factor involved in the pathogenesis of thyroid cancer, and targeted down-regulation of TAK1 may improve the prognosis of patients with thyroid cancer.

  7. Loss of MAP3K7 are associated with esophageal squamous cell carcinoma.

  8. This paper highlights that targeting the BMP and TGFbeta (show TGFB1 Antibodies) type I and type II receptors causes a downregulation of XIAP (show XIAP Antibodies), TAK1, and Id1 (show ID1 Antibodies) leading to cell death of lung cancer cells.

  9. Polyubiquitination of Transforming Growth Factor beta-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4 (show TLR4 Antibodies)-mediated JNK (show MAPK8 Antibodies) and p38 MAPK (show MAPK14 Antibodies) Activation

  10. The data emphasize the central role of TAK1 in controlling signaling cascades and functional responses in primary neutrophils, making it a promising target for therapeutic intervention in view of the role of neutrophils in chronic inflammatory conditions.

Mouse (Murine) Mitogen-Activated Protein Kinase Kinase Kinase 7 (MAP3K7) interaction partners

  1. TAK1 (show NR2C2 Antibodies) regulates Nrf2 (show NFE2L2 Antibodies) through modulation of Keap-p62/SQSTM1 (show SQSTM1 Antibodies) interaction. This regulation is important for homeostatic antioxidant protection in the intestinal epithelium.

  2. Mekk1 (show MAP2K1 Antibodies) (encoded by Map3k1 (show MAP3K1 Antibodies)) signaling activates Mapks to regulate Cdkn1b (show CDKN1B Antibodies) (encoding p27(Kip1 (show CDKN1B Antibodies))) expression and p27(Kip1 (show CDKN1B Antibodies))-dependent proliferative expansion in response to antigen.

  3. TRADD (show TRADD Antibodies) knockout blunts pressure overload-induced cardiac hypertrophy through mediating TAK1 (show NR2C2 Antibodies)/p38 MAPK (show MAPK14 Antibodies) but not AKT (show AKT1 Antibodies) phosphorylation

  4. this study demonstrates a pivotal role of TAK1 (show NR2C2 Antibodies) in dendritic cells in controlling trichloroethylene-induced contact hypersensitivity response and suggests that targeting TAK1 (show NR2C2 Antibodies) function in DCs may be a viable approach to preventing and treating TCE-related occupational health hazards

  5. The E3 ligase TRIM8 (show TRIM8 Antibodies) is a potent regulator that exacerbates steatohepatitis and metabolic disorders dependent on its binding and ubiquitinating capacity on transforming growth factor-beta-activated kinase 1.

  6. Angiotensin-II up-regulates the Ampkalpha1 (show PRKAA1 Antibodies) isoform in renal tissue. Ampkalpha1 (show PRKAA1 Antibodies) participates in renal Tak1 (show NR2C2 Antibodies) activation and Tak1 (show NR2C2 Antibodies)-dependent signaling induced by angiotensin-II.

  7. TRIM8 (show TRIM8 Antibodies) could promote K63-linked polyubiquitination of transforming growth factor beta-activated kinase 1 (TAK1), leading to the activation of TAK1 (show NR2C2 Antibodies) and enhanced inflammatory responses.

  8. TAK1 (show NR2C2 Antibodies) signaling preserved the viability of lambda-chain-positive B cells by maintaining Bcl-2 (show BCL2 Antibodies) expression through IKK (show CHUK Antibodies)-NF-kappaB (show NFKB1 Antibodies) signaling

  9. Data show that TGFbeta (show TGFB1 Antibodies)-activated kinase-1 (TAK1 (show NR2C2 Antibodies)) activated nuclear factor of activated T-cells (NFAT (show NFATC1 Antibodies))/NF-kappa B (NFkappaB (show NFKB1 Antibodies)), downregulated BCL2-adenovirus E1B interacting protein 3 (Bnip3 (show BNIP3 Antibodies)), and inhibited cardiac cell death.

  10. Crucial functions of inflammatory TAK1 (show NR2C2 Antibodies)-NEMO (show IKBKG Antibodies) signaling in protecting the brain endothelium and maintaining normal brain function.

MAP3K7 Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2\; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported.

Alternative names and synonyms associated with MAP3K7

  • mitogen activated protein kinase kinase kinase 7 (map3k7) antibody
  • mitogen activated protein kinase kinase kinase 7 (Map3k7) antibody
  • mitogen-activated protein kinase kinase kinase 7 (MAP3K7) antibody
  • mitogen-activated protein kinase kinase kinase 7 (Map3k7) antibody
  • B430101B05 antibody
  • C87327 antibody
  • MEKK7 antibody
  • si:ch211-225h9.1 antibody
  • TAK1 antibody
  • TGF1a antibody
  • zgc:110612 antibody

Protein level used designations for MAP3K7

mitogen-activated protein kinase kinase kinase 7 , tak1 , TGF-beta-activated kinase TAK1 , TGF-beta activated kinase 1 , TGF-beta-activated kinase 1 , transforming growth factor-beta-activated kinase 1 , mitogen activated protein kinase kinase kinase 7 , transforming growth factor beta-activated kinase 1

GENE ID SPECIES
553788 Danio rerio
313121 Rattus norvegicus
6885 Homo sapiens
26409 Mus musculus
529146 Bos taurus
100171454 Pongo abelii
Selected quality suppliers for anti-MAP3K7 (MAP3K7) Antibodies
Did you look for something else?